.Pharmacolibrary.Drugs.C_CardiovascularSystem.C10B_LipidModifyingAgentsCombinations.C10BA09_RosuvastatinAndFenofibra.RosuvastatinAndFenofibra .Pharmacolibrary.Drugs.C_CardiovascularSystem.C10B_LipidModifyingAgentsCombinations.C10BA09_RosuvastatinAndFenofibra.RosuvastatinAndFenofibra| name: | RosuvastatinAndFenofibrate |
| ATC code: | C10BA09 | route: | oral |
| n-compartments | 1 |
Rosuvastatin and fenofibrate is a fixed-dose combination medication that includes rosuvastatin, a statin used to lower cholesterol and reduce cardiovascular risk, and fenofibrate, a fibrate that lowers triglycerides and increases HDL cholesterol. This combination is used in the management of mixed dyslipidemia and hyperlipidemia, and is currently approved for clinical use in various countries.
No published clinical pharmacokinetic (PK) population or compartmental model specific to the fixed-dose combination of rosuvastatin and fenofibrate was identified. PK parameters are estimated based on available literature for the individual components when administered orally in healthy adult subjects.